Brief: Lee's Pharmaceutical Says Trazodone Hydrochloride Tablet Obtained Drug Registration Certificate From NMPA
11/12/2020 14:29
Dec 11 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* TRAZODONE HYDROCHLORIDE TABLET OBTAINED DRUG REGISTRATION
CERTIFICATE FROM CHINA'S NMPA
* TRITTICO FOR TREATMENT OF DEPRESSION
Source text for Eikon: ID:nHKSbYZZtr
Further company coverage: 0950.HK
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals